Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biocon Ltd. Interim / Quarterly Report 2020

Nov 21, 2019

61176_rns_2019-11-21_a5fac072-d569-4c1a-8959-23331d2ff23a.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

==> picture [147 x 29] intentionally omitted <==

==> picture [455 x 93] intentionally omitted <==

==> picture [97 x 44] intentionally omitted <==

==> picture [78 x 77] intentionally omitted <==

Nameofrelatedparties Natureofrelationship
Keymanagement personnelKiranMazumdar-ShawArun ChandavarkarSiddharthMittalMayank VermaRussellWallsDaniel M BradburyJeremy MLevinMary HarneyVijay K KuchrooM DamodaranBobby K ParikhJohn ShawRaviMazumdarJoint VenturesNeoBioconFZLLCOther related partiesBiocon Foundationlmmuneel Therapeutics Private LimitedMazumdar Shaw Medical FoundationGlentec International LimitedCatherine RosenbergJeevesNarayana Hrudayalaya LimitedP K Associates Chairperson&Managing DirectorJoint Managing Director&CEOPresident- Finance and Chief Financial OfficerCompany Secretary (w.e.f July 25, 2019)Independent director (upto July,25 2019)Independent directorIndependent directorIndependent directorIndependent directorIndependent directorIndependent directorNon-executive directorNon-executive directorJoint-ventureTrust in which key management personnel are the BoardofTrusteesEnterprise in which a directoroftheCompanyisa shareholderTrust in which key management personnel are the BoardofTrusteesEnterprise owned by key management personnelRelativeofa directorEnterpriseinwhich relativetoa directorofthe CompanyisproprietorEnterprise in which a directoroftheCompanyisa memberofboardofdirectorsProprietary firmofrelativeofdirector
Particulars Transactions_I_Balances Half year endedSeptember 30,2019
Key management personnelJointVentureOther related parties Salary and perquisites [refer note (a)&(b) below]Sitting fees and commissionOutstandingasattheperiod end:-Trade andotherpayablesPurchaseofgoodsSalespromotion expensesExpensesincurred on behalfoftherelated partyOutstandingasat the period end:-Trade and other receivables-Trade and other payablesSaleofgoodsSaleofservicesHealth services availedExpensestowards Scientific and Research servicesCSRExpenditureOther expensesOutstandingasat the period end:-Trade and other receivables-Trade and otherpayables 63184108122•-24443•-2123212313

==> picture [79 x 80] intentionally omitted <==